The company’s large-scale manufacturing of non-core process liquids have been outsourced to third party manufacturers to free up cGMP manufacturing space and eliminate the need for additional capital expenditures to expand manufacturing footprint. The company’s support from their traditional media hydration and buffer manufacturers decreased due to overall market demand and capacity constraints.
The company experienced price and service variation, extended lead-times, and poor delivery to promise date. The overall communication level with key suppliers suffered, increasing the company’s operational costs and risk. As a result, the company needed to partner with a process liquid manufacturer that was committed to meeting customer service commitment levels.
GeminiBio collaborated with the company to document the detailed product specifications and requirements, including all component specifications and release criteria requirements, completing feasibility and the custom product proposal within 10 days for the company’s custom buffers.
The company required multiple 10,000-liter batches of salt solutions delivered on specific dates over the forecasted time period. GeminiBio scheduled manufacturing in accordance with forecast schedule to ensure company received product with market leading OTIF.
GeminiBio has demonstrated flexibility in working with the company by adjusting manufacturing schedule and delivery to meet the company’s request for accelerated product shipment.
As a result of GeminiBio’s TrueCustomTM and ExpressCustomTM service models the company has been able to improve operational efficiency while reducing risk.